Recent findings also show that m6A modification stabilizes TRPM7 mRNA through IGF2BP2-mediated mechanisms, upregulating TRPM7 expression in NSCLC (42). The gene discussed is IGF2BP2; the disease is non-small cell lung carcinoma.